Profile data is unavailable for this security.
About the company
Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.
- Revenue in SEK (TTM)2.27m
- Net income in SEK-218.33m
- Incorporated2007
- Employees97.00
- LocationQ linea ABDag Hammarskjolds Vag 52 AUPPSALA 752 37SwedenSWE
- Phone+46 184443610
- Websitehttps://www.qlinea.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SciBase Holding AB (publ) | 26.87m | -64.21m | 86.94m | 27.00 | -- | 2.29 | -- | 3.24 | -0.4237 | -0.4237 | 0.1665 | 0.1726 | 0.3851 | 0.7222 | 3.30 | 995,185.20 | -92.01 | -68.63 | -122.20 | -87.77 | 72.29 | 61.28 | -238.95 | -300.20 | 2.44 | -14.84 | 0.00 | -- | 29.93 | 27.50 | -28.75 | -- | 5.15 | -- |
| Dignitana AB | 86.49m | -25.27m | 96.65m | 29.00 | -- | 9.88 | -- | 1.12 | -0.3268 | -0.3268 | 1.13 | 0.1215 | 1.74 | 2.76 | 15.19 | 3,203,482.00 | -50.91 | -42.21 | -122.38 | -68.91 | 69.56 | 66.09 | -29.22 | -57.29 | 0.5202 | -9.97 | 0.609 | -- | 17.90 | 20.59 | 22.52 | -- | -15.31 | -- |
| Episurf Medical AB | 12.80m | -79.70m | 98.17m | 26.00 | -- | 0.9679 | -- | 7.67 | -0.2072 | -0.2072 | 0.0301 | 0.1558 | 0.1059 | -- | 5.57 | 457,142.80 | -66.09 | -47.46 | -75.45 | -52.01 | -- | -- | -624.22 | -1,019.29 | 6.17 | -- | 0.0296 | -- | 53.62 | 19.78 | -22.64 | -- | -0.4158 | -- |
| Immunovia AB (publ) | 885.00k | -116.12m | 98.43m | 10.00 | -- | 2.68 | -- | 111.22 | -1.30 | -1.30 | 0.0099 | 0.2162 | 0.0071 | -- | 14.39 | 80,454.55 | -93.50 | -41.33 | -133.56 | -44.24 | -6,702.03 | -7,553.76 | -13,120.79 | -20,879.29 | -- | 2.48 | 0.3064 | -- | 37.55 | 36.48 | -84.09 | -- | -50.93 | -- |
| Observe Medical ASA | -99.90bn | -99.90bn | 101.16m | 5.00 | -- | 0.646 | -- | -- | -- | -- | -- | 0.5635 | -- | -- | -- | -- | -- | -32.60 | -- | -49.80 | -- | 32.83 | -- | -256.25 | 0.193 | -- | 0.3425 | -- | 43.14 | 204.81 | -18.82 | -- | 32.69 | -- |
| Redsense Medical AB (publ) | 23.77m | -3.98m | 103.93m | 5.00 | -- | 3.24 | -- | 4.37 | -0.2871 | -0.2871 | 1.65 | 1.95 | 0.7524 | 7.58 | 4.18 | 4,754,400.00 | -12.58 | -18.66 | -14.51 | -20.99 | 20.47 | -2.72 | -16.72 | -46.28 | 4.00 | -89.34 | 0.00 | -- | 74.11 | 28.94 | 48.47 | -- | -23.62 | -- |
| Iconovo AB | 2.92m | -40.21m | 106.55m | 28.00 | -- | 0.7154 | -- | 36.54 | -2.74 | -2.74 | 0.196 | 7.02 | 0.0215 | -- | 1.14 | 100,561.70 | -29.61 | -25.43 | -33.16 | -28.24 | 635.97 | 134.57 | -1,378.66 | -215.16 | -- | -1,179.07 | 0.0668 | -- | -58.65 | -9.88 | 4.71 | -- | 34.70 | -- |
| Luxbright AB | 4.20m | -22.23m | 110.43m | 10.00 | -- | 3.71 | -- | 26.28 | -0.24 | -0.24 | 0.0454 | 0.2641 | 0.104 | -- | 4.14 | 420,270.00 | -55.02 | -61.39 | -62.23 | -70.36 | -134.43 | -577.85 | -528.90 | -2,529.11 | 0.7743 | -4,539.47 | 0.0084 | -- | 55.58 | -- | -20.07 | -- | -- | -- |
| Vo2 Cap Holding AB (publ) | 348.03m | -55.15m | 112.06m | 94.00 | -- | 0.6226 | -- | 0.322 | -0.9759 | -0.9759 | 6.46 | 3.16 | 0.7992 | -- | 8.21 | 3,378,952.00 | -12.66 | -0.2564 | -17.29 | -0.3839 | 35.78 | 23.36 | -15.84 | -0.2409 | -- | -6.95 | 0.1429 | -- | -26.09 | 85.65 | -57.92 | -- | -17.96 | -- |
| BibbInstruments AB | 0.00 | -12.21m | 116.81m | 4.00 | -- | 3.63 | -- | -- | -0.4477 | -0.4477 | 0.00 | 1.10 | 0.00 | -- | -- | -- | -34.78 | -39.57 | -36.66 | -42.71 | -- | 59.36 | -- | -8,032.40 | 4.41 | -- | 0.00 | -- | -- | -- | 2.72 | -- | -1.94 | -- |
| Q linea AB | 2.27m | -218.33m | 128.88m | 97.00 | -- | 5.02 | -- | 56.88 | -1.87 | -1.87 | 0.0194 | 0.219 | 0.0107 | 0.1224 | 3.01 | 17,842.52 | -103.05 | -59.66 | -149.74 | -66.14 | -124.10 | -378.58 | -9,635.17 | -4,046.97 | 0.4141 | -- | 0.7825 | -- | -65.28 | 33.02 | 14.64 | -- | 41.94 | -- |
| Glycorex Transplantation AB (publ) | 31.03m | -27.83m | 129.17m | 15.00 | -- | 3.53 | -- | 4.16 | -0.3768 | -0.3768 | 0.4201 | 0.5186 | 0.412 | 0.8382 | 3.69 | 1,348,913.00 | -36.96 | -11.30 | -46.32 | -13.17 | 82.91 | 91.60 | -89.70 | -33.24 | 1.09 | -71.86 | 0.2084 | -- | -17.04 | -2.15 | -254.06 | -- | -0.5593 | -- |
| Arcoma AB | 171.33m | 12.98m | 144.38m | 32.00 | 11.12 | 2.45 | 7.05 | 0.8427 | 0.9844 | 0.9844 | 12.99 | 4.48 | 1.87 | 3.48 | 7.87 | 5,526,807.00 | 14.18 | 1.12 | 24.21 | 2.01 | 38.29 | 37.66 | 7.58 | 0.7568 | 1.24 | 25.82 | 0.00 | 0.00 | 30.36 | 6.41 | 34.81 | -- | 22.75 | -- |
| SpectraCure AB (publ) | 2.36m | -21.18m | 153.66m | 13.00 | -- | 1.30 | -- | 65.00 | -0.218 | -0.218 | 0.0243 | 1.21 | 0.0166 | -- | 24.63 | 157,600.00 | -14.82 | -12.75 | -15.91 | -13.62 | 442.39 | 195.30 | -895.85 | -494.40 | -- | -- | 0.0494 | -- | -3.30 | -- | 19.46 | -- | -- | -- |
| Toleranzia AB | 0.00 | -7.12m | 153.91m | 11.00 | -- | 0.7548 | -- | -- | -0.0361 | -0.0361 | 0.00 | 0.7526 | 0.00 | -- | -- | 0.00 | -4.31 | -7.45 | -4.56 | -7.78 | -- | -- | -- | -- | -- | -- | 0.0481 | -- | -- | -- | 11.79 | -- | 63.90 | -- |
| Bactiquant A/S | 13.96m | -22.50m | 154.76m | -- | -- | 14.59 | -- | 11.09 | -0.6558 | -0.6558 | 0.4064 | 0.2906 | 0.5101 | 2.94 | 5.06 | -- | -82.23 | -41.26 | -92.65 | -47.16 | -24.34 | 12.89 | -161.20 | -71.77 | 2.73 | -9.48 | 0.5326 | -- | -0.689 | -- | 7.62 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to Q linea AB's reporting currency: Swedish Krona SEK
10.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fj�rde AP-fondenas of 30 Jun 2024 | 8.90m | 7.59% |
| Aktie-Ansvar ABas of 30 Jun 2024 | 1.22m | 1.04% |
| Handelsbanken Fonder ABas of 31 Oct 2024 | 680.03k | 0.58% |
| SEB Investment Management ABas of 31 Oct 2024 | 601.72k | 0.51% |
| FCG Fonder ABas of 31 Oct 2024 | 399.45k | 0.34% |
| Skandia Investment Management ABas of 30 Sep 2024 | 24.94k | 0.02% |
| Storebrand Asset Management ASas of 30 Sep 2024 | 17.00k | 0.02% |
| SSgA Funds Management, Inc.as of 07 Nov 2024 | 694.00 | 0.00% |
| Danske Bank A/S (Investment Management)as of 31 Oct 2024 | 330.00 | 0.00% |
| AXA Investment Managers (Paris) SAas of 31 Oct 2023 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
